A Meta-Analysis of Functional Neuroimaging Studies of Ketamine Administration in Healthy Volunteers

References

• Abdallah, C. G., K.H. Ahn, L. A. Averill, S. Nemati, C. L. Averill, S. Fouda, M. Ranganathan, P. T. Morgan, D. C. D’souza, D. H. Mathalon, et al. 2021. A robust and reproducible connectome fingerprint of ketamine is highly associated with the connectomic signature of antidepressants. Neuropsychopharmacology. 46(2):478–85. doi:10.1038/s41386-020-00864-9.
   PubMed Web of Science ®Google Scholar
• Abel, K. M., M. P. G. Allin, K. Kucharska-Pietura, A. David, C. Andrew, S. Williams, M. J. Brammer, and M. L. Phillips. 2003 March. Ketamine alters neural processing of facial emotion recognition in healthy men: An FMRI study. NeuroReport 387–91. doi:10.1097/00001756-200303030-00018.
   PubMed Web of Science ®Google Scholar
• Albajes-Eizagirre, A., A. Solanes, E. Vieta, and J. Radua. 2019. Voxel-based meta-analysis via permutation of subject images (PSI): Theory and implementation for SDM. NeuroImage 186 (February):174–84. doi:10.1016/j.neuroimage.2018.10.077.
   PubMedGoogle Scholar
• Alexander, L., L. A. Jelen, M. A. Mehta, and A. H. Young. 2021. The anterior cingulate cortex as a key locus of ketamine’s antidepressant action. Neuroscience & Biobehavioral Reviews 127 (August):531–54. doi:10.1016/j.neubiorev.2021.05.003.
   PubMedGoogle Scholar
• Anders, E., T. E. Nichols, and H. Knutsson. 2016. Cluster failure: Why FMRI inferences for spatial extent have inflated false-positive rates. Proceedings of the National Academy of Sciences 113 (28):7900–05. doi:10.1073/pnas.1602413113.
   PubMed Web of Science ®Google Scholar
• Andrade, C. 2017. Ketamine for depression, 4: In what dose, at what rate, by what route, for how long, and at what frequency? The Journal of Clinical Psychiatry 78 (7):e852–57. doi:10.4088/JCP.17f11738.
   PubMed Web of Science ®Google Scholar
• Anticevic, A., M. Gancsos, J. D. Murray, G. Repovs, N. R. Driesen, D. J. Ennis, M. J. Niciu, P. T. Morgan, T. S. Surti, M. H. Bloch, et al. 2012. NMDA receptor function in large-scale anticorrelated neural systems with implications for cognition and schizophrenia. Proceedings of the National Academy of Sciences. 109(41):16720–25. doi:10.1073/pnas.1208494109.
   PubMed Web of Science ®Google Scholar
• Ballard, E. D., and C. A. Zarate. 2020. The role of dissociation in ketamine’s antidepressant effects. Nature Communications 11 (1):6431. doi:10.1038/s41467-020-20190-4.
   PubMed Web of Science ®Google Scholar
• Becker, B., M. Steffens, Z. Zhao, K. M. Kendrick, C. Neumann, B. Weber, J. Schultz, M. A. Mehta, U. Ettinger, and R. Hurlemann. 2017. General and emotion-specific neural effects of ketamine during emotional memory formation. NeuroImage 150 (April):308–17. doi:10.1016/j.neuroimage.2017.02.049.
   PubMedGoogle Scholar
• Beck, K., G. Hindley, F. Borgan, C. Ginestet, R. McCutcheon, S. Brugger, N. Driesen, M. Ranganathan, D. D'Souza, M. Taylor, et al. 2020. Association of ketamine with psychiatric symptoms and implications for its therapeutic use and for understanding schizophrenia: A systematic review and meta-analysis. JAMA Network Open 3 (5):e204693. doi:10.1001/jamanetworkopen.2020.4693.
   PubMed Web of Science ®Google Scholar
• Benoit, R. G., and D. L. Schacter. 2015. Specifying the core network supporting episodic simulation and episodic memory by activation likelihood estimation. Neuropsychologia 75 (August):450–57. doi:10.1016/j.neuropsychologia.2015.06.034.
   PubMedGoogle Scholar
• Bernard, J. A., and R. D. Seidler. 2013. Cerebellar contributions to visuomotor adaptation and motor sequence learning: An ALE meta-analysis. Frontiers in Human Neuroscience 7:7. doi:10.3389/fnhum.2013.00027.
   PubMed Web of Science ®Google Scholar
• Bolton, T. A. W., D. Wotruba, R. Buechler, A. Theodoridou, L. Michels, S. Kollias, W. Rössler, K. Heekeren, and D. Van De Ville. 2020. Triple network model dynamically revisited: Lower salience network state switching in pre-psychosis. Frontiers in Physiology 11 (February):66. doi:10.3389/fphys.2020.00066.
   PubMedGoogle Scholar
• Bonnelle, V., T. E. Ham, R. Leech, K. M. Kinnunen, M. A. Mehta, R. J. Greenwood, and D. J. Sharp. 2012. Salience network integrity predicts default mode network function after traumatic brain injury. Proceedings of the National Academy of Sciences 109 (12):4690–95. doi:10.1073/pnas.1113455109.
   PubMed Web of Science ®Google Scholar
• Bora, E., A. Fornito, M. Yücel, and C. Pantelis. 2012. The effects of gender on grey matter abnormalities in major psychoses: A comparative voxelwise meta-analysis of schizophrenia and bipolar disorder. Psychological Medicine 42 (2):295–307. doi:10.1017/S0033291711001450.
   PubMed Web of Science ®Google Scholar
• Breier, A., A. K. Malhotra, D. A. Pinals, N. I. Weisenfeld, and D. Pickar. 1997. Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers. The American Journal of Psychiatry 154 (6):805–11. doi:10.1176/ajp.154.6.805.
   PubMed Web of Science ®Google Scholar
• Chen, X., S. Liang, P. Weidan, Y. Song, T. E. Mwansisya, Q. Yang, H. Liu, Z. Liu, B. Shan, and Z. Xue. 2015. Reduced cortical thickness in right heschl’s gyrus associated with auditory verbal hallucinations severity in first-episode schizophrenia. BMC Psychiatry 15 (1):152. doi:10.1186/s12888-015-0546-2.
   PubMedGoogle Scholar
• Choudhury, D., A. E. Autry, K. F. Tolias, and V. Krishnan. 2021. Ketamine: Neuroprotective or neurotoxic? Frontiers in Neuroscience 15 (September):672526. doi:10.3389/fnins.2021.672526.
   PubMedGoogle Scholar
• Corlett, P. R., G. D. Honey, M. R. F. Aitken, A. Dickinson, D. R. Shanks, A. R. Absalom, M. Lee, E. Pomarol-Clotet, G. K. Murray, P. J. McKenna, et al. 2006. Frontal responses during learning predict vulnerability to the psychotogenic effects of ketamine: Linking cognition, brain activity, and psychosis. Archives of General Psychiatry. 63(6):611. doi:10.1001/archpsyc.63.6.611.
   PubMed Web of Science ®Google Scholar
• Ćurčić-Blake, B., J. M. Ford, D. Hubl, N. D. Orlov, I. E. Sommer, F. Waters, P. Allen, R. Jardri, P. W. Woodruff, O. David, et al. 2017. Interaction of language, auditory and memory brain networks in auditory verbal hallucinations. Progress in Neurobiology. 148(January):1–20. doi:10.1016/j.pneurobio.2016.11.002.
   PubMedGoogle Scholar
• Da Costa, S., W. van der Zwaag, J. P. Marques, R. S. J. Frackowiak, S. Clarke, and M. Saenz. 2011. Human primary auditory cortex follows the shape of heschl’s gyrus. Journal of Neuroscience 31 (40):14067–75. doi:10.1523/JNEUROSCI.2000-11.2011.
   PubMed Web of Science ®Google Scholar
• Dahlgren, K., C. Ferris, and S. Hamann. 2020. Neural correlates of successful emotional episodic encoding and retrieval: An SDM meta-analysis of neuroimaging studies. Neuropsychologia 143 (June):107495. doi:10.1016/j.neuropsychologia.2020.107495.
   PubMedGoogle Scholar
• Daumann, J., K. Heekeren, A. Neukirch, C. M. Thiel, W. Möller-Hartmann, and E. Gouzoulis-Mayfrank. 2008. Pharmacological modulation of the neural basis underlying inhibition of return (IOR) in the human 5-HT2A agonist and NMDA antagonist model of psychosis. Psychopharmacology 200 (4):573–83. doi:10.1007/s00213-008-1237-1.
   PubMed Web of Science ®Google Scholar
• Daumann, J., D. Wagner, K. Heekeren, A. Neukirch, C. Thiel, and E. Gouzoulis-Mayfrank. 2010. Neuronal correlates of visual and auditory alertness in the DMT and ketamine model of psychosis. Journal of Psychopharmacology 24 (10):1515–24. doi:10.1177/0269881109103227.
   PubMed Web of Science ®Google Scholar
• Deakin, J. F. Lees, S. William, J. Lees, S. McKie, E. C. H. Jaime, S. R. Williams, and M. D. Serdar. 2008. Glutamate and the neural basis of the subjective effects of ketamine: A pharmaco–magnetic resonance imaging study. Archives of General Psychiatry 65 (2):154. doi:10.1001/archgenpsychiatry.2007.37.
   PubMed Web of Science ®Google Scholar
• De Simoni, S., A. J. Schwarz, O. G. O’daly, A. F. Marquand, C. Brittain, C. Gonzales, S. Stephenson, S. C. R. Williams, and M. A. Mehta. 2013. Test–retest reliability of the BOLD pharmacological MRI response to ketamine in healthy volunteers. NeuroImage 64 (January):75–90. doi:10.1016/j.neuroimage.2012.09.037.
   PubMedGoogle Scholar
• Ebert, A., I. Sibylle Haussleiter, G. Juckel, M. Brüne, and P. Roser. 2012. Impaired facial emotion recognition in a ketamine model of psychosis. Psychiatry Research 200 (2–3):724–27. doi:10.1016/j.psychres.2012.06.034.
   PubMed Web of Science ®Google Scholar
• Egerton, A., A. A. Grace, J. Stone, M. G. Bossong, M. Sand, and P. McGuire. 2020. Glutamate in schizophrenia: Neurodevelopmental perspectives and drug development. Schizophrenia Research 223 (September):59–70. doi:10.1016/j.schres.2020.09.013.
   PubMedGoogle Scholar
• Egger, M., G. D. Smith, M. Schneider, and C. Minder. 1997. Bias in meta-analysis detected by a simple, graphical test. The BMJ 315 (7109):629–34. doi:10.1136/bmj.315.7109.629.
   PubMed Web of Science ®Google Scholar
• Ferrarelli, F. 2020. Ketamine, NMDA hypofunction, and sleep oscillatory abnormalities in schizophrenia. Schizophrenia Research 222 (August):1–2. doi:10.1016/j.schres.2020.06.009.
   PubMedGoogle Scholar
• Fletcher, J. 2007. What is heterogeneity and is it important? The BMJ 334 (7584):94–96. doi:10.1136/bmj.39057.406644.68.
   PubMed Web of Science ®Google Scholar
• Francois, J., O. Grimm, A. J. Schwarz, J. Schweiger, L. Haller, C. Risterucci, A. Böhringer, Z. Zang, H. Tost, G. Gilmour, et al. 2016. Ketamine suppresses the ventral striatal response to reward anticipation: A cross-species translational neuroimaging study. Neuropsychopharmacology. 41(5):1386–94. doi:10.1038/npp.2015.291.
   PubMed Web of Science ®Google Scholar
• Fu, C. H. Y., K. M. Abel, M. P. G. Allin, D. Gasston, S. G. Costafreda, J. Suckling, S. C. R. Williams, and P. K. McGuire. 2005. Effects of ketamine on prefrontal and striatal regions in an overt verbal fluency task: A functional magnetic resonance imaging study. Psychopharmacology 183 (1):92–102. doi:10.1007/s00213-005-0154-9.
   PubMed Web of Science ®Google Scholar
• Gao, Z., W. Zhao, S. Liu, Z. Liu, C. Yang, and X. Yong. 2021. Facial emotion recognition in schizophrenia. Frontiers in Psychiatry 12 (May):633717. doi:10.3389/fpsyt.2021.633717.
   PubMedGoogle Scholar
• Gärtner, M., A. Weigand, M. Scheidegger, M. Lehmann, P. O. Wyss, A. Wunder, A. Henning, and S. Grimm. 2022. Acute effects of ketamine on the pregenual anterior cingulate: linking spontaneous activation, functional connectivity, and glutamate metabolism. European Archives of Psychiatry and Clinical Neuroscience 272 (4):703–14. doi:10.1007/s00406-021-01377-2.
   PubMed Web of Science ®Google Scholar
• Gavrilescu, M., S. Rossell, G. W. Stuart, T. L. Shea, H. Innes-Brown, K. Henshall, C. McKay, A. A. Sergejew, D. Copolov, and G. F. Egan. 2010. Reduced connectivity of the auditory cortex in patients with auditory hallucinations: A resting state functional magnetic resonance imaging study. Psychological Medicine 40 (7):1149–58. doi:10.1017/S0033291709991632.
   PubMed Web of Science ®Google Scholar
• Guo, Q., H. Yang, B. Zeng, Y. Tang, L. Guanjun, T. Zhang, J. Wang, G. Northoff, C. Li, D. Goff, et al. 2020. Parietal memory network and default mode network in first‐episode drug‐naïve schizophrenia: Associations with auditory hallucination. Human Brain Mapping. 41(8):1973–84. doi:10.1002/hbm.24923.
   PubMed Web of Science ®Google Scholar
• Gyula, B., and P. D. Anderson. 2014. Ketamine: An update on its abuse. Journal of Pharmacy Practice 27 (6):582–86. doi:10.1177/0897190014525754.
   PubMedGoogle Scholar
• Higgins, J. P. T. 2003. Measuring inconsistency in meta-analyses. The BMJ 327 (7414):557–60. doi:10.1136/bmj.327.7414.557.
   PubMed Web of Science ®Google Scholar
• Höflich, A., A. Hahn, M. Küblböck, G. S. Kranz, T. Vanicek, S. Ganger, M. Spies, C. Windischberger, S. Kasper, D. Winkler, et al. 2017. Ketamine-dependent neuronal activation in healthy volunteers. Brain Structure & Function. 222(3):1533–42. doi:10.1007/s00429-016-1291-0.
   PubMed Web of Science ®Google Scholar
• Holcomb, H. 2001. Sequential regional cerebral blood flow brain scans using PET with H215O demonstrate ketamine actions in CNS dynamically. Neuropsychopharmacology 25 (2):165–72. doi:10.1016/S0893-133X(01)00229-9.
   PubMed Web of Science ®Google Scholar
• Honey, G. D., P. R. Corlett, A. R. Absalom, M. Lee, E. Pomarol-Clotet, G. K. Murray, P. J. McKenna, E. T. Bullmore, D. K. Menon, and P. C. Fletcher. 2008. Individual differences in psychotic effects of ketamine are predicted by brain function measured under placebo. Journal of Neuroscience 28 (25):6295–303. doi:10.1523/JNEUROSCI.0910-08.2008.
   PubMed Web of Science ®Google Scholar
• Honey, R. A. E., G. D. Honey, C. O’loughlin, S. R. Sharar, D. Kumaran, E. T. Bullmore, D. K. Menon, V. C. Lupson, R. Bisbrown-Chippendale, and P. C. Fletcher. 2004. Acute ketamine administration alters the brain responses to executive demands in a verbal working memory task: An FMRI study. Neuropsychopharmacology 29 (6):1203–14. doi:10.1038/sj.npp.1300438.
   PubMed Web of Science ®Google Scholar
• Honey, G. D., R. A. E. Honey, C. O’loughlin, S. R. Sharar, D. Kumaran, J. Suckling, D. K. Menon, C. Sleator, E. T. Bullmore, and P. C. Fletcher. 2005. Ketamine disrupts frontal and hippocampal contribution to encoding and retrieval of episodic memory: An FMRI study. Cerebral Cortex 15 (6):749–59. doi:10.1093/cercor/bhh176.
   PubMed Web of Science ®Google Scholar
• Javitt, D. C., C. S. Carter, J. H. Krystal, J. T. Kantrowitz, R. R. Girgis, L. S. Kegeles, J. D. Ragland, R. J. Maddock, T. A. Lesh, C. Tanase, et al. 2018. Utility of imaging-based biomarkers for glutamate-targeted drug development in psychotic disorders: A randomized clinical trial. JAMA Psychiatry. 75(1):11. doi:10.1001/jamapsychiatry.2017.3572.
   PubMed Web of Science ®Google Scholar
• Karnath, H.O., and B. Baier. 2010. Right insula for our sense of limb ownership and self-awareness of actions. Brain Structure & Function 214 (5–6):411–17. doi:10.1007/s00429-010-0250-4.
   PubMed Web of Science ®Google Scholar
• Kotoula, V., T. Webster, J. Stone, and M. A. Mehta. 2021. Resting-state connectivity studies as a marker of the acute and delayed effects of subanaesthetic ketamine administration in healthy and depressed individuals: A systematic review. Brain and Neuroscience Advances 5 (January):239821282110554. doi:10.1177/23982128211055426.
   Google Scholar
• Krystal, J. H., C. G. Abdallah, G. Sanacora, D. S. Charney, and R. S. Duman. 2019. Ketamine: A paradigm shift for depression research and treatment. Neuron 101 (5):774–78. doi:10.1016/j.neuron.2019.02.005.
   PubMed Web of Science ®Google Scholar
• Krystal, J. H., L. P. Karper, J. P. Seibyl, G. K. Freeman, R. Delaney, J. D. Bremner, G. R. Heninger, M. B. Bowers, and D. S. Charney. 1994. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Archives of General Psychiatry 51 (3):199–214. doi:10.1001/archpsyc.1994.03950030035004.
   PubMed Web of Science ®Google Scholar
• Kurdi, M., K. Theerth, and R. Deva. 2014. Ketamine: Current applications in anesthesia, pain, and critical care. Anesthesia: Essays and Researches 8 (3):283. doi:10.4103/0259-1162.143110.
   PubMedGoogle Scholar
• Lally, N., A. C. Nugent, D. A. Luckenbaugh, R. Ameli, J. P. Roiser, and C. A. Zarate. 2014. Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression. Translational Psychiatry 4 (10):e469. doi:10.1038/tp.2014.105.
   PubMed Web of Science ®Google Scholar
• Lally, N., A. C. Nugent, D. A. Luckenbaugh, M. J. Niciu, J. P. Roiser, and C. A. Zarate. 2015. Neural correlates of change in major depressive disorder anhedonia following open-label ketamine. Journal of Psychopharmacology 29 (5):596–607. doi:10.1177/0269881114568041.
   PubMed Web of Science ®Google Scholar
• Lancaster, J. L., A. R. Laird, S. B. Eickhoff, M. J. Martinez, P. Mickle Fox, and P. T. Fox. 2012. Automated regional behavioral analysis for human brain images. Frontiers in Neuroinformatics 6:6. doi:10.3389/fninf.2012.00023.
   PubMed Web of Science ®Google Scholar
• Lehmann, M., C. Neumann, S. Wasserthal, J. Schultz, A. Delis, P. Trautner, R. Hurlemann, and U. Ettinger. 2021. Effects of ketamine on brain function during metacognition of episodic memory. Neuroscience of Consciousness 2021 (1):niaa028. doi:10.1093/nc/niaa028.
   PubMedGoogle Scholar
• Lena, P., and P. F. Liddle. 2012. Does the salience network play a cardinal role in psychosis? An emerging hypothesis of insular dysfunction. Journal of Psychiatry & Neuroscience 37 (1):17–27. doi:10.1503/jpn.100176.
   PubMed Web of Science ®Google Scholar
• Lennox, B. R., S. B. G. Park, I. Medley, P. G. Morris, and P. B. Jones. 2000. The functional anatomy of auditory hallucinations in schizophrenia. Psychiatry Research: Neuroimaging 100 (1):13–20. doi:10.1016/S0925-4927(00)00068-8.
   PubMed Web of Science ®Google Scholar
• Limongi, R., P. Jeon, M. Mackinley, T. Das, K. Dempster, J. Théberge, R. Bartha, D. Wong, and L. Palaniyappan. 2020. Glutamate and dysconnection in the salience network: neurochemical, effective connectivity, and computational evidence in schizophrenia. Biological Psychiatry 88 (3):273–81. doi:10.1016/j.biopsych.2020.01.021.
   PubMed Web of Science ®Google Scholar
• Lindquist, K. A., A. B. Satpute, T. D. Wager, J. Weber, and L. Feldman Barrett. 2016. The brain basis of positive and negative affect: Evidence from a meta-analysis of the human neuroimaging literature. Cerebral Cortex 26 (5):1910–22. doi:10.1093/cercor/bhv001.
   PubMed Web of Science ®Google Scholar
• Luckenbaugh, D. A., M. J. Niciu, D. F. Ionescu, N. M. Nolan, E. M. Richards, N. E. Brutsche, S. Guevara, and C. A. Zarate. 2014. Do the dissociative side effects of ketamine mediate its antidepressant effects? Journal of Affective Disorders 159 (April):56–61. doi:10.1016/j.jad.2014.02.017.
   PubMedGoogle Scholar
• Martino, D., M. M. Federico, X. Junqian, P.F. van de Moortele, K. Ugurbil, R. Goebel, E. Yacoub, and E. Formisano. 2015. High-resolution mapping of myeloarchitecture in vivo: Localization Of auditory areas in the human brain. Cerebral Cortex 25 (10):3394–405. doi:10.1093/cercor/bhu150.
   PubMed Web of Science ®Google Scholar
• Mathai, D. S., M. J. Meyer, E. A. Storch, and T. R. Kosten. 2020. The relationship between subjective effects induced by a single dose of ketamine and treatment response in patients with major depressive disorder: A systematic review. Journal of Affective Disorders 264 (March):123–29. doi:10.1016/j.jad.2019.12.023.
   PubMedGoogle Scholar
• Meng, L., M. Woelfer, L. Colic, A. Safron, C. Chang, H.J. Heinze, O. Speck, H. S. Mayberg, B. B. Biswal, G. Salvadore, et al. 2020. Default mode network connectivity change corresponds to ketamine’s delayed glutamatergic effects. European Archives of Psychiatry and Clinical Neuroscience. 270(2):207–16. doi:10.1007/s00406-018-0942-y.
   PubMed Web of Science ®Google Scholar
• Mion, G., and T. Villevieille. 2013. Ketamine pharmacology: An update (PHARMACODYNAMICS AND MOLECULAR ASPECTS, RECENT FINDINgs). CNS Neuroscience & Therapeutics 19 (6):370–80. doi:10.1111/cns.12099.
   PubMed Web of Science ®Google Scholar
• Modinos, G., S. G. Costafreda, M.J. van Tol, P. K. McGuire, A. Aleman, and P. Allen. 2013. Neuroanatomy of auditory verbal hallucinations in schizophrenia: A quantitative meta-analysis of voxel-based morphometry studies. Cortex 49 (4):1046–55. doi:10.1016/j.cortex.2012.01.009.
   PubMed Web of Science ®Google Scholar
• Moerel, M., F. De Martino, and E. Formisano. July 2014. An anatomical and functional topography of human auditory cortical areas. Frontiers in Neuroscience 8. doi:10.3389/fnins.2014.00225.
   PubMed Web of Science ®Google Scholar
• Morgan, H. L., D. C. Turner, P. R. Corlett, A. R. Absalom, R. Adapa, F. S. Arana, J. Pigott, J. Gardner, J. Everitt, P. Haggard, et al. 2011. Exploring the impact of ketamine on the experience of illusory body ownership. Biological Psychiatry. 69(1):35–41. doi:10.1016/j.biopsych.2010.07.032.
   PubMed Web of Science ®Google Scholar
• Musso, F., J. Brinkmeyer, D. Ecker, M. K. London, G. Thieme, T. Warbrick, H.J. Wittsack, A. Saleh, W. Greb, P. de Boer, et al. 2011. Ketamine effects on brain function — simultaneous FMRI/EEG during a visual oddball task. NeuroImage. 58(2):508–25. doi:10.1016/j.neuroimage.2011.06.045.
   PubMed Web of Science ®Google Scholar
• Nagels, A., M. Cabanis, A. Oppel, A. Kirner-Veselinovic, C. Schales, and T. Kircher. 2018. S-Ketamine-induced NMDA receptor blockade during natural speech production and its implications for formal thought disorder in schizophrenia: A pharmaco-FMRI study. Neuropsychopharmacology 43 (6):1324–33. doi:10.1038/npp.2017.270.
   PubMed Web of Science ®Google Scholar
• Nagels, A., A. Kirner-Veselinovic, S. Krach, and T. Kircher. 2011. Neural correlates of S-Ketamine induced psychosis during overt continuous verbal fluency. NeuroImage 54 (2):1307–14. doi:10.1016/j.neuroimage.2010.08.021.
   PubMed Web of Science ®Google Scholar
• Niesters, M., C. Martini, and A. Dahan. 2014. Ketamine for chronic pain: Risks and benefits: ketamine risks and benefits. British Journal of Clinical Pharmacology 77 (2):357–67. doi:10.1111/bcp.12094.
   PubMed Web of Science ®Google Scholar
• Northoff, G., A. Richter, F. Bermpohl, S. Grimm, E. Martin, V. Leslie Marcar, C. Wahl, D. Hell, and H. Boeker. 2005. NMDA hypofunction in the posterior cingulate as a model for schizophrenia: an exploratory ketamine administration study in FMRI. Schizophrenia Research 72 (2–3):235–48. doi:10.1016/j.schres.2004.04.009.
   PubMed Web of Science ®Google Scholar
• Page, M. J., J. E. McKenzie, P. M. Bossuyt, I. Boutron, T. C. Hoffmann, C. D. Mulrow, L. Shamseer, J. M. Tetzlaff, E. A. Akl, S. E. Brennan, et al. 2021. The PRISMA 2020 statement : An updated guideline for reporting systematic reviews. PLoS medicine 18 (3):e1003583. doi:10.1371/journal.pmed.1003583.
   PubMed Web of Science ®Google Scholar
• Pollak, T. A., S. De Simoni, B. Barimani, F. O. Zelaya, J. M. Stone, and M. A. Mehta. 2015. Phenomenologically distinct psychotomimetic effects of ketamine are associated with cerebral blood flow changes in functionally relevant cerebral foci: A continuous arterial spin labelling study. Psychopharmacology 232 (24):4515–24. doi:10.1007/s00213-015-4078-8.
   PubMed Web of Science ®Google Scholar
• Potvin, S., J. Pelletier, S. Grot, C. Hébert, A. M. Barr, and T. Lecomte. 2018. Cognitive deficits in individuals with methamphetamine use disorder: A meta-analysis. Addictive Behaviors 80 (May):154–60. doi:10.1016/j.addbeh.2018.01.021.
   PubMedGoogle Scholar
• Potvin, S., K. Stavro, É. Rizkallah, and J. Pelletier. 2014. Cocaine and cognition: A systematic quantitative review. Journal of Addiction Medicine 8 (5):368–76. doi:10.1097/ADM.0000000000000066.
   PubMed Web of Science ®Google Scholar
• Powers, A. R., III, M. G. Gancsos, E. S. Finn, P. T. Morgan, and P. R. Corlett. 2015. Ketamine-induced hallucinations. Psychopathology 48 (6):376–85. doi:10.1159/000438675.
   PubMed Web of Science ®Google Scholar
• Pribish, A., N. Wood, and A. Kalava. 2020. A review of nonanesthetic uses of ketamine. Anesthesiology Research and Practice 2020 (April):1–15. doi:10.1155/2020/5798285.
   Google Scholar
• Radua, J., S. Borgwardt, A. Crescini, D. Mataix-Cols, A. Meyer-Lindenberg, P. K. McGuire, and P. Fusar-Poli. 2012. Multimodal meta-analysis of structural and functional brain changes in first episode psychosis and the effects of antipsychotic medication. Neuroscience & Biobehavioral Reviews 36 (10):2325–33. doi:10.1016/j.neubiorev.2012.07.012.
   PubMed Web of Science ®Google Scholar
• Radua, J., and D. Mataix-Cols. 2012. Meta-analytic methods for neuroimaging data explained. Biology of Mood & Anxiety Disorders 2 (1):6. doi:10.1186/2045-5380-2-6.
   PubMedGoogle Scholar
• Rowland, L. M., L. Beason-Held, C. A. Tamminga, and H. H. Holcomb. 2010. The interactive effects of ketamine and nicotine on human cerebral blood flow. Psychopharmacology 208 (4):575–84. doi:10.1007/s00213-009-1758-2.
   PubMed Web of Science ®Google Scholar
• Rubin, D. B. 2004. Multiple imputation for nonresponse in surveys, Vol. 81. John Wiley & Sons.
   Google Scholar
• Russo, J. F., and S. A. Sheth. 2015. Deep brain stimulation of the dorsal anterior cingulate cortex for the treatment of chronic neuropathic pain. Neurosurgical Focus 38 (6):E11. doi:10.3171/2015.3.FOCUS1543.
   PubMed Web of Science ®Google Scholar
• Sander, C. Y., and S. Hesse. 2017. News and views on in-vivo imaging of neurotransmission using PET and MRI. The Quarterly Journal of Nuclear Medicine and Molecular Imaging 61 (4):4. doi:10.23736/S1824-4785.17.03019-9.
   Web of Science ®Google Scholar
• Scheidegger, M., A. Henning, M. Walter, H. Boeker, A. Weigand, E. Seifritz, and S. Grimm. 2016. Effects of ketamine on cognition–emotion interaction in the brain. NeuroImage 124 (January):8–15. doi:10.1016/j.neuroimage.2015.08.070.
   PubMedGoogle Scholar
• Simon, Z., V. Tourjman, J. Pelletier, R. Assaf, C.S.R. Li, and S. Potvin. 2022. Acute effects of ketamine and esketamine on cognition in healthy subjects: A meta-analysis. Progress in Neuro-Psychopharmacology & Biological Psychiatry 118 (August):110575. doi:10.1016/j.pnpbp.2022.110575.
   PubMedGoogle Scholar
• Smith, S., and T. Nichols. 2009. Threshold-free cluster enhancement: Addressing problems of smoothing, threshold dependence and localisation in cluster inference. NeuroImage 44 (1):83–98. doi:10.1016/j.neuroimage.2008.03.061.
   PubMed Web of Science ®Google Scholar
• Sos, P., M. Klirova, T. Novak, B. Kohutova, J. Horacek, and T. Palenicek. 2013. Relationship of ketamine’s antidepressant and psychotomimetic effects in unipolar depression. Neuro Endocrinology Letters 34 (4):287–93.
   PubMed Web of Science ®Google Scholar
• Sprenger, T., M. Valet, R. Woltmann, C. Zimmer, R. Freynhagen, E. F. Kochs, T. R. Tölle, and K. J. Wagner. 2006. Imaging pain modulation by subanesthetic S-(+)-ketamine:. Anesthesia & Analgesia 103 (3):729–37. doi:10.1213/01.ane.0000231635.14872.40.
   PubMed Web of Science ®Google Scholar
• Stavro, K., J. Pelletier, and S. Potvin. 2013. Widespread and sustained cognitive deficits in alcoholism: A meta-analysis: alcoholism and cognition. Addiction Biology 18 (2):203–13. doi:10.1111/j.1369-1600.2011.00418.x.
   PubMed Web of Science ®Google Scholar
• Steffens, M., B. Becker, C. Neumann, A. M. Kasparbauer, I. Meyhöfer, B. Weber, M. A. Mehta, R. Hurlemann, and U. Ettinger. 2016. Effects oF ketamine on brain function during smooth pursuit eye movements: Effects of ketamine on brain function. Human Brain Mapping 37 (11):4047–60. doi:10.1002/hbm.23294.
   PubMed Web of Science ®Google Scholar
• Steffens, M., C. Neumann, A. -M. Kasparbauer, B. Becker, B. Weber, M. A. Mehta, R. Hurlemann, and U. Ettinger. 2018. Effects of ketamine on brain function during response inhibition. Psychopharmacology 235 (12):3559–71. doi:10.1007/s00213-018-5081-7.
   PubMed Web of Science ®Google Scholar
• Stone, J. M., K. M. Abel, M. P. Allin, N. van Haren, K. Matsumoto, P. K. McGuire, and C. H. Fu. 2011 JanDec. Ketamine-induced disruption of verbal self-monitoring linked to superior temporal activation. Pharmacopsychiatry. 44(1): 33–48. doi:10.1055/s-0030-1267942. Epub. 2010 13
   PubMed Web of Science ®Google Scholar
• Takahashi, T., D. Sasabayashi, Y. Takayanagi, A. Furuichi, H. Kobayashi, K. Noguchi, and M. Suzuki. 2022. Different heschl’s gyrus duplication patterns in deficit and non-deficit subtypes of schizophrenia. Frontiers in Psychiatry 13 (June):867461. doi:10.3389/fpsyt.2022.867461.
   PubMedGoogle Scholar
• Takahashi, T., D. Sasabayashi, Y. Takayanagi, Y. Higuchi, Y. Mizukami, S. Nishiyama, A. Furuichi, M. Kido, T. V. Pham, and H. Kobayashi, et al. 2021. Heschl’s gyrus duplication pattern in individuals at risk of developing psychosis and patients with schizophrenia. Frontiers in Behavioral Neuroscience 15 (April):647069. doi:10.3389/fnbeh.2021.647069.
   PubMedGoogle Scholar
• Thomas, D., D. E. J. Linden, M. Jandl, E. Formisano, R. Goebel, H. Lanfermann, and W. Singer. 1999. Activation oF heschl’s gyrus during auditory hallucinations. Neuron 22 (3):615–21. doi:10.1016/S0896-6273(00)80715-1.
   PubMed Web of Science ®Google Scholar
• Uddin, L. Q., J. S. Nomi, B. Hébert-Seropian, J. Ghaziri, and O. Boucher. 2017. Structure and function of the human insula:. Journal of Clinical Neurophysiology 34 (4):300–06. doi:10.1097/WNP.0000000000000377.
   PubMed Web of Science ®Google Scholar
• van Erp, T. G. M., E. Walton, D. P. Hibar, L. Schmaal, W. Jiang, D. C. Glahn, G. D. Pearlson, N. Yao, M. Fukunaga, R. Hashimoto, et al. 2018. Cortical brain abnormalities in 4474 individuals with schizophrenia and 5098 control subjects via the enhancing neuro imaging genetics through meta analysis (ENIGMA) consortium. Biological Psychiatry. 84(9):644–54. doi:10.1016/j.biopsych.2018.04.023.
   PubMed Web of Science ®Google Scholar
• Ven, V. G. V. D., E. Formisano, C. H. Röder, D. Prvulovic, R. A. Bittner, M. G. Dietz, D. Hubl, T. Dierks, A. Federspiel, F. Esposito, et al. 2005. The spatiotemporal pattern of auditory cortical responses during verbal hallucinations. NeuroImage. 27(3):644–55. doi:10.1016/j.neuroimage.2005.04.041.
   PubMed Web of Science ®Google Scholar
• Vinckier, F., R. Gaillard, S. Palminteri, L. Rigoux, A. Salvador, A. Fornito, R. Adapa, M. O. Krebs, M. Pessiglione, and P. C. Fletcher. 2016. Confidence and psychosis: A neuro-computational account of contingency learning disruption by NMDA blockade. Molecular Psychiatry 21 (7):946–55. doi:10.1038/mp.2015.73.
   PubMed Web of Science ®Google Scholar
• Wasserthal, C., A. Brechmann, J. Stadler, B. Fischl, and K. Engel. 2014. Localizing the human primary auditory cortex in vivo using structural MRI. NeuroImage 93 (June):237–51. doi:10.1016/j.neuroimage.2013.07.046.
   PubMedGoogle Scholar
• Yang, A., and S.J. Tsai. 2017. New targets for schizophrenia treatment beyond the dopamine hypothesis. International Journal of Molecular Sciences 18 (8):1689. doi:10.3390/ijms18081689.
   PubMed Web of Science ®Google Scholar
• Yurgelun-Todd, D. A., P. F. Renshaw, P. Goldsmith, U. Tolga, and T. A. Macek. 2020. A randomized, placebo-controlled, phase 1 study to evaluate the effects of TAK-063 on ketamine-induced changes in FMRI BOLD signal in healthy subjects. Psychopharmacology 237 (2):317–28. doi:10.1007/s00213-019-05366-1.
   PubMed Web of Science ®Google Scholar
• Zanos, P., and T. D. Gould. 2018. Mechanisms of ketamine action as an antidepressant. Molecular Psychiatry 23 (4):801–11. doi:10.1038/mp.2017.255.
   PubMed Web of Science ®Google Scholar
• Zhang, X., Y. Qiu, L. Jinhui, C. Jia, J. Liao, K. Chen, L. Qiu, Z. Yuan, and R. Huang. 2022. NeuraL correlates of transitive inference: An SDM meta-analysis on 32 FMRI studies. NeuroImage 258 (September):119354. doi:10.1016/j.neuroimage.2022.119354.
   PubMedGoogle Scholar
• Zhou, G., J. Liu, N. G. Xiao, W. Si Jia, L. Hong, and K. Lee. 2018. The fusiform face area plays a greater role in holistic processing for own-race faces than other-race faces. Frontiers in Human Neuroscience 12 (June):220. doi:10.3389/fnhum.2018.00220.
   PubMedGoogle Scholar